Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;17(2):77-86.
doi: 10.1111/pedi.12242. Epub 2014 Dec 10.

Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents

Lorraine E Levitt Katz  1 , Kevin A Gralewski  1 , Pamela Abrams  2 , Preneet C Brar  3 , Paul R Gallagher  4 , Terri H Lipman  1 , Lee J Brooks  5 , Dorit Koren  6
Affiliations

Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents

Lorraine E Levitt Katz et al. Pediatr Diabetes. 2016 Mar.

Abstract

Context: Insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 have been linked to cardiovascular disease (CVD) risk and pathophysiology in adults, but there are limited data in youth.

Objective: The aim of the study was to examine the relationship between IGF and IGFBP-1 with traditional and non-traditional CVD risk factors including inflammatory markers and body composition in an obese pediatric cohort.

Design: A cross-sectional study.

Setting: The study was carried out at a university children's hospital.

Subjects: Sixty-one obese non-diabetic adolescents.

Outcomes: Fasting IGF-I, IGFBP-1, lipoprotein profiles, high-sensitivity C-reactive protein (hsCRP), and total adiponectin as well as insulin sensitivity measures, blood pressure (BP), and anthropometrics.

Results: IGFBP-1 was negatively associated with insulin sensitivity measures, body mass index (BMI), and diastolic BP in males. IGF-I was negatively associated with hsCRP (r = -0.479, p < 0.0005), and IGFBP-1 was positively associated with adiponectin (r = 0.545, p < 0.0005). The IGF-I/CRP and IGFBP-1/adiponectin associations remained significant when controlling for both BMI and insulin sensitivity index (SI ). Both IGF-I and IGFBP-1 were negatively associated with waist circumference (r = -0.327 and r = -0.275, respectively) and sagittal abdominal diameter (r = -0.333 and r = -0.371, respectively), while IGFBP-1 was negatively associated with fat mass (r = -0.347, p = 0.01) as well as neck circumference and fat-free mass in males. Controlling for BMI z-score and SI , IGFBP-1 remained negatively associated with diastolic blood pressure (r = 0.706, p = 0.001 and neck circumference (r = -0.548, p = 0.15) in males.

Conclusions: IGF-I and IGFBP-1 associate with CVD risk markers and may add to clinical assessments of cardiometabolic dysfunction in youth.

Keywords: CVD risk factors; IGF-I; IGFBP-1; adiponectin; neck circumference.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

K. A. G., P. A., P. C. B., P. R. G., L. J. B., T. L., and D. K. have nothing to declare. L. L. K. consults for Janssen Pharmaceuticals and Takeda Pharmaceuticals.

Figures

Fig. 1
Fig. 1
The linear relationships between adipocytokines and growth factors: (A) CRP and IGF-I and (B) adiponectin with the natural log values of IGFBP-1 serum levels.
See this image and copyright information in PMC

References

    1. van Bunderen CC, Oosterwerff MM, Schoor Van, Deeg DJ, Lips P, Drent ML. Serum IGF1, metabolic syndrome, and incident cardiovascular disease in older people: a population-based study. Eur J Endocrinol. 2013;168:393–401. - PubMed
    1. Reinehr T, Kleber M, Toschke AM, Woelfle J, Roth CL. Longitudinal association between IGFBP-1 levels and parameters of the metabolic syndrome in obese children before and after weight loss. Int J Pediatr Obes. 2011;6:236–243. - PubMed
    1. Katz LEL, Rosenfeld RG, Cohen SP. Clinical-significance of insulin-like growth-factor binding-proteins (IGFbps) Endocrinologist. 1995;5:36–43.
    1. Katz LE, DeLeon DD, Zhao H, Jawad AF. Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1. J Clin Endocrinol Metab. 2002;87:2978–2983. - PubMed
    1. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case control study. Circulation. 2002;106:939–944. - PubMed

Publication types

Substances